NEW MJ NEWS

Tilray Brands, Inc. to Announce Third Quarter 2024 Financial Results on April 9, 2024

Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced that the Company will release financial results for its third quarter ended February 29, 2024, on April 9, 2024.

Live Audio Webcast

Tilray will host a live audio webcast to discuss these results at 8:30 am Eastern Time, which can be accessed on the Investors section of Tilray’s website at www.Tilray.com. A replay will be available and archived on the Company’s website.

Retail Investor Q&A

Tilray Brands stockholders can submit and upvote questions via the stockholder Q&A platform Say Technologies beginning today and until April 8, 2024. To submit questions ahead of the webcast, please visit the Say Technologies platform at https://app.saytechnologies.com/tilray-brands-2024-q3.

About Tilray Brands

Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY) is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people’s lives for the better – one person at a time – by inspiring and empowering the worldwide community to live their very best life by providing them with products that meet the needs of their mind, body, and soul and invoke a sense of wellbeing. Tilray’s mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience and health and well-being through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and alcoholic beverages.

For more information on how we open a world of well-being, visit, www.Tilray.com and follow @tilray on all social platforms.

Contacts:

Media:
Berrin Noorata
news@tilray.com

Investors
Raphael Gross
203-682-8253
Raphael.Gross@icrinc.com


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$PLPL Phytofare(R) Catechin Complex Hits the Shelves With New USN Label

Plandai Biotechnology’s Phytofare(R) Catechin Complex Hits the Shelves With New USN Label…

Tetra Bio-Pharma Inc.(TBPMF) Obtains Health Canada Approval for Renewal of its Veterinary Clinical Study

Tetra Bio-Pharma Obtains Health Canada Approval for Renewal of its Veterinary Clinical…

Reliq Health Technologies Inc. (RQHTF) Announces Call-In Details for Quarterly Reporting Call, and Launch of New iUGO Care Website

Reliq Health Announces Call-In Details for Quarterly Reporting Call, and Launch of…